Navigation Links
InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
Date:12/22/2008

International supplier of animal free, productivity enhancing cell culture media components offers its customers the chance to improve performance of cell culture development and bioproduction.

Fort Collins, CO (PRWEB) December 18, 2008 -- The 2008 Cell Engineering Conference, hosted by the Williamsburg BioProcessing Foundation, featured the products and supporting research data of InVitria, a company committed to delivering affordable, high-performing cell culture media components for bioproduction and regenerative medicine applications.

Over the course of the three day conference in Santa Barbara, CA, InVitria exhibited its Cellastim and Lacromin cell culture media component products to industry leaders seeking ways to improve their development timelines and optimize bioproduction.

InVitria's Director of Cell Culture, Dr. Steve Pettit, presented at the meeting and revealed data from a study entitled, "Recombinant Human Serum Albumin Expressed in Plants Improves the Productivity and Growth Kinetics of CHO." Tests have shown that Cellastim outperforms plasma-derived human serum albumin and can result in improved doubling time and an average 50% increase in productivity across a variety of chemically defined cell culture media.

"WilBio's Cell Engineering Conference was a great venue for InVitria to learn about the cell line development challenges facing the biopharmaceutical industry," said InVitria President Scott Deeter. "InVitria is dedicated to working with customers to improve cell line development speed by improving doubling time and expediting the development process without the use of serum or other animal components," Deeter said.

About InVitria
InVitria's Cellastim and Lacromin are animal free components used to enhance cell growth, reduce doubling times and optimize productivity in cell culture media. Cellastim and Lacromin are well-defined media components that improve performance for research, development and bioproduction.

For more information about InVitria's products, please contact us by e-mail or phone.

Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/WILBIO/INVITRIA/prweb1771634.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
2. Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
3. New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
4. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
5. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
6. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
7. KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
8. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
9. LGE Execs Teams with Texas Tech to License Advancements in Agriculture, Health and Life Sciences
10. Improved culture system for hepatitis C virus infection
11. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
Breaking Biology News(10 mins):